Development of a heterogeneous P–N–N tridentate ligand for iridium-catalyzed asymmetric hydrogenation of ketones in batch and flow
Green Chemistry · 2025 · 27 (14) · 3684-3692
DOI: 10.1039/d5gc00487j ↗Kurz gefasst
Fachartikel in der Zeitschrift Green Chemistry, 2025. Verfasst von Lizhou Zheng und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
An unprecedented P–N–N tridentate ligand was developed for iridium catalyzed hydrogenation of ketones, with up to >99% ee, 99 : 1 dr and a higher total TON in both batch and flow processes compared to its homogeneous counterpart.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zheng, L., Feng, W., Chen, C., Feng, K., Song, D., Chen, Y., Shen, F., Zhao, X., Ling, F., & Zhong, W. (2025). Development of a heterogeneous P–N–N tridentate ligand for iridium-catalyzed asymmetric hydrogenation of ketones in batch and flow. Green Chemistry, 27(14), 3684-3692. https://doi.org/10.1039/d5gc00487j
Vancouver
Zheng L, Feng W, Chen C, Feng K, Song D, Chen Y, et al. Development of a heterogeneous P–N–N tridentate ligand for iridium-catalyzed asymmetric hydrogenation of ketones in batch and flow. Green Chemistry. 2025;27(14):3684-3692. doi:10.1039/d5gc00487j
BibTeX
@article{Zheng2025,
author = {Zheng, Lizhou and Feng, Weiqi and Chen, Chen and Feng, Ke and Song, Dingguo and Chen, Yirui and Shen, Feiyang and Zhao, Xianghua and Ling, Fei and Zhong, Weihui},
title = {Development of a heterogeneous P–N–N tridentate ligand for iridium-catalyzed asymmetric hydrogenation of ketones in batch and flow},
journal = {Green Chemistry},
year = {2025},
volume = {27},
number = {14},
pages = {3684--3692},
doi = {10.1039/d5gc00487j}
}
EUVIMED